Legis Daily

CREATES Act of 2019

USA116th CongressHR-965| House 
| Updated: 5/16/2019
David N. Cicilline

David N. Cicilline

Democratic Representative

Rhode Island

Cosponsors (68)
Kim Schrier (Democratic)Donald Norcross (Democratic)F. James Sensenbrenner (Republican)Tom Cole (Republican)Gilbert Ray Cisneros (Democratic)Sylvia R. Garcia (Democratic)Chris Pappas (Democratic)Mark Meadows (Republican)Joseph P. Kennedy (Democratic)Abigail Davis Spanberger (Democratic)James R. Langevin (Democratic)Ben McAdams (Democratic)Ed Case (Democratic)Chrissy Houlahan (Democratic)Raul Ruiz (Democratic)Jefferson Van Drew (Republican)Joe Courtney (Democratic)David Scott (Democratic)Bobby L. Rush (Democratic)Debbie Dingell (Democratic)Steve Cohen (Democratic)Jennifer Wexton (Democratic)Doug Collins (Republican)Paul Tonko (Democratic)Angie Craig (Democratic)Jim Jordan (Republican)Scott Perry (Republican)David B. McKinley (Republican)Ro Khanna (Democratic)Greg Stanton (Democratic)Kurt Schrader (Democratic)John B. Larson (Democratic)David P. Joyce (Republican)Jim Cooper (Democratic)Rodney Davis (Republican)Doris O. Matsui (Democratic)Jerrold Nadler (Democratic)Theodore E. Deutch (Democratic)Anna G. Eshoo (Democratic)Lucy McBath (Democratic)Betty McCollum (Democratic)Sharice Davids (Democratic)Mike Gallagher (Republican)Daniel Lipinski (Democratic)Anthony Gonzalez (Republican)Abby Finkenauer (Democratic)Salud O. Carbajal (Democratic)Jamie Raskin (Democratic)Mike Quigley (Democratic)Sean Casten (Democratic)Debbie Mucarsel-Powell (Democratic)Janice D. Schakowsky (Democratic)Andy Kim (Democratic)Adam Smith (Democratic)Yvette D. Clarke (Democratic)Peter Welch (Democratic)Colin Z. Allred (Democratic)Ralph Norman (Republican)Jason Crow (Democratic)Frank Pallone (Democratic)Grace Meng (Democratic)Cheri Bustos (Democratic)Louie Gohmert (Republican)Lloyd Doggett (Democratic)Gerald E. Connolly (Democratic)Lauren Underwood (Democratic)Chellie Pingree (Democratic)Susan Wild (Democratic)

Administrative State, Regulatory Reform, and Antitrust Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Creating and Restoring Equal Access to Equivalent Samples Act of 2019 or the CREATES Act of 2019 This bill generally allows the developer of a drug or biological product, such as a generic or biosimilar version of a drug, to bring a civil action against the license holder of an approved medication if the holder refuses to make available sufficient quantities of the approved medication for the developer's testing. The bill also establishes affirmative defenses to such a civil action. In addition, the bill authorizes drug manufacturers seeking Food and Drug Administration approval for a generic drug to use alternative methods to develop elements assure safe use of a drug.

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 5, 2019
Introduced in House
Feb 5, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 6, 2019

Latest Companion Bill Action

S 116-340
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
Feb 6, 2019
Referred to the Subcommittee on Health.
Mar 22, 2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Mar 27, 2019
Subcommittee Consideration and Mark-up Session Held.
Mar 27, 2019
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Apr 3, 2019
Committee Consideration and Mark-up Session Held.
Apr 3, 2019
Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.
Apr 30, 2019
Committee Consideration and Mark-up Session Held.
Apr 30, 2019
Ordered to be Reported by Voice Vote.
May 10, 2019
Placed on the Union Calendar, Calendar No. 33.
May 10, 2019
Reported by the Committee on Judiciary. H. Rept. 116-55, Part II.
May 10, 2019
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-55, Part I.
May 16, 2019
Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.
May 16, 2019
PERMISSION TO FILE SUPPLEMENTAL - Ms. Lofgren asked unanimous consent that Committee on the Judiciary be authorized to file a supplemental report on the bill, H.R. 965. Agreed to without objection.
  • February 5, 2019
    Introduced in House


  • February 5, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • February 6, 2019

    Latest Companion Bill Action

    S 116-340
    Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.


  • February 6, 2019
    Referred to the Subcommittee on Health.


  • March 22, 2019
    Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.


  • March 27, 2019
    Subcommittee Consideration and Mark-up Session Held.


  • March 27, 2019
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • April 3, 2019
    Committee Consideration and Mark-up Session Held.


  • April 3, 2019
    Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.


  • April 30, 2019
    Committee Consideration and Mark-up Session Held.


  • April 30, 2019
    Ordered to be Reported by Voice Vote.


  • May 10, 2019
    Placed on the Union Calendar, Calendar No. 33.


  • May 10, 2019
    Reported by the Committee on Judiciary. H. Rept. 116-55, Part II.


  • May 10, 2019
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-55, Part I.


  • May 16, 2019
    Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.


  • May 16, 2019
    PERMISSION TO FILE SUPPLEMENTAL - Ms. Lofgren asked unanimous consent that Committee on the Judiciary be authorized to file a supplemental report on the bill, H.R. 965. Agreed to without objection.

Health

Related Bills

  • HR 116-1865: Further Consolidated Appropriations Act, 2020
  • S 116-340: CREATES Act of 2019
  • HR 116-3947: Competition Prescription Act of 2019
  • HR 116-2700: Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
  • S 116-1895: Lower Health Care Costs Act
  • HR 116-19: Lower Costs, More Cures Act of 2019
  • HR 116-987: Strengthening Health Care and Lowering Prescription Drug Costs Act
Civil actions and liabilityDrug safety, medical device, and laboratory regulationLicensing and registrationsPrescription drugsProduct development and innovation

CREATES Act of 2019

USA116th CongressHR-965| House 
| Updated: 5/16/2019
Creating and Restoring Equal Access to Equivalent Samples Act of 2019 or the CREATES Act of 2019 This bill generally allows the developer of a drug or biological product, such as a generic or biosimilar version of a drug, to bring a civil action against the license holder of an approved medication if the holder refuses to make available sufficient quantities of the approved medication for the developer's testing. The bill also establishes affirmative defenses to such a civil action. In addition, the bill authorizes drug manufacturers seeking Food and Drug Administration approval for a generic drug to use alternative methods to develop elements assure safe use of a drug.

Bill Text Versions

View Text
2 versions available

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 5, 2019
Introduced in House
Feb 5, 2019
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Feb 6, 2019

Latest Companion Bill Action

S 116-340
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
Feb 6, 2019
Referred to the Subcommittee on Health.
Mar 22, 2019
Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.
Mar 27, 2019
Subcommittee Consideration and Mark-up Session Held.
Mar 27, 2019
Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .
Apr 3, 2019
Committee Consideration and Mark-up Session Held.
Apr 3, 2019
Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.
Apr 30, 2019
Committee Consideration and Mark-up Session Held.
Apr 30, 2019
Ordered to be Reported by Voice Vote.
May 10, 2019
Placed on the Union Calendar, Calendar No. 33.
May 10, 2019
Reported by the Committee on Judiciary. H. Rept. 116-55, Part II.
May 10, 2019
Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-55, Part I.
May 16, 2019
Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.
May 16, 2019
PERMISSION TO FILE SUPPLEMENTAL - Ms. Lofgren asked unanimous consent that Committee on the Judiciary be authorized to file a supplemental report on the bill, H.R. 965. Agreed to without objection.
  • February 5, 2019
    Introduced in House


  • February 5, 2019
    Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.


  • February 6, 2019

    Latest Companion Bill Action

    S 116-340
    Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.


  • February 6, 2019
    Referred to the Subcommittee on Health.


  • March 22, 2019
    Referred to the Subcommittee on Antitrust, Commercial, and Administrative Law.


  • March 27, 2019
    Subcommittee Consideration and Mark-up Session Held.


  • March 27, 2019
    Forwarded by Subcommittee to Full Committee (Amended) by Voice Vote .


  • April 3, 2019
    Committee Consideration and Mark-up Session Held.


  • April 3, 2019
    Ordered to be Reported (Amended) by the Yeas and Nays: 50 - 0.


  • April 30, 2019
    Committee Consideration and Mark-up Session Held.


  • April 30, 2019
    Ordered to be Reported by Voice Vote.


  • May 10, 2019
    Placed on the Union Calendar, Calendar No. 33.


  • May 10, 2019
    Reported by the Committee on Judiciary. H. Rept. 116-55, Part II.


  • May 10, 2019
    Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 116-55, Part I.


  • May 16, 2019
    Supplemental report filed by the Committee on the Judiciary, H. Rept. 116-55, Part III.


  • May 16, 2019
    PERMISSION TO FILE SUPPLEMENTAL - Ms. Lofgren asked unanimous consent that Committee on the Judiciary be authorized to file a supplemental report on the bill, H.R. 965. Agreed to without objection.
David N. Cicilline

David N. Cicilline

Democratic Representative

Rhode Island

Cosponsors (68)
Kim Schrier (Democratic)Donald Norcross (Democratic)F. James Sensenbrenner (Republican)Tom Cole (Republican)Gilbert Ray Cisneros (Democratic)Sylvia R. Garcia (Democratic)Chris Pappas (Democratic)Mark Meadows (Republican)Joseph P. Kennedy (Democratic)Abigail Davis Spanberger (Democratic)James R. Langevin (Democratic)Ben McAdams (Democratic)Ed Case (Democratic)Chrissy Houlahan (Democratic)Raul Ruiz (Democratic)Jefferson Van Drew (Republican)Joe Courtney (Democratic)David Scott (Democratic)Bobby L. Rush (Democratic)Debbie Dingell (Democratic)Steve Cohen (Democratic)Jennifer Wexton (Democratic)Doug Collins (Republican)Paul Tonko (Democratic)Angie Craig (Democratic)Jim Jordan (Republican)Scott Perry (Republican)David B. McKinley (Republican)Ro Khanna (Democratic)Greg Stanton (Democratic)Kurt Schrader (Democratic)John B. Larson (Democratic)David P. Joyce (Republican)Jim Cooper (Democratic)Rodney Davis (Republican)Doris O. Matsui (Democratic)Jerrold Nadler (Democratic)Theodore E. Deutch (Democratic)Anna G. Eshoo (Democratic)Lucy McBath (Democratic)Betty McCollum (Democratic)Sharice Davids (Democratic)Mike Gallagher (Republican)Daniel Lipinski (Democratic)Anthony Gonzalez (Republican)Abby Finkenauer (Democratic)Salud O. Carbajal (Democratic)Jamie Raskin (Democratic)Mike Quigley (Democratic)Sean Casten (Democratic)Debbie Mucarsel-Powell (Democratic)Janice D. Schakowsky (Democratic)Andy Kim (Democratic)Adam Smith (Democratic)Yvette D. Clarke (Democratic)Peter Welch (Democratic)Colin Z. Allred (Democratic)Ralph Norman (Republican)Jason Crow (Democratic)Frank Pallone (Democratic)Grace Meng (Democratic)Cheri Bustos (Democratic)Louie Gohmert (Republican)Lloyd Doggett (Democratic)Gerald E. Connolly (Democratic)Lauren Underwood (Democratic)Chellie Pingree (Democratic)Susan Wild (Democratic)

Administrative State, Regulatory Reform, and Antitrust Subcommittee, Health Subcommittee, Judiciary Committee, Energy and Commerce Committee

Health

Related Bills

  • HR 116-1865: Further Consolidated Appropriations Act, 2020
  • S 116-340: CREATES Act of 2019
  • HR 116-3947: Competition Prescription Act of 2019
  • HR 116-2700: Lowering Prescription Drug Costs and Extending Community Health Centers and Other Public Health Priorities Act
  • S 116-1895: Lower Health Care Costs Act
  • HR 116-19: Lower Costs, More Cures Act of 2019
  • HR 116-987: Strengthening Health Care and Lowering Prescription Drug Costs Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Civil actions and liabilityDrug safety, medical device, and laboratory regulationLicensing and registrationsPrescription drugsProduct development and innovation